Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Target on the Defensive After Removing LGBTQ+-Themed Products
Target once distinguished itself as being boldly supportive of the LGBTQ+ community. Now that status is tarnished after it removed some LGBTQ+-themed products and relocated Pride Month displays to the back of stores in certain Southern locations in response to online complaints and in-store confrontations that it says threatened employees’ well-being.
Load More